comparemela.com

Latest Breaking News On - Bttx - Page 3 : comparemela.com

NetEase, Inc (NASDAQ:NTES) Short Interest Down 18 9% in April

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) was the recipient of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 129,800 shares, a decrease of 30.3% from the April 15th total of 186,200 shares. Currently, 6.7% of the company’s shares are short sold. Based […]

Better Therapeutics, Inc (NASDAQ:BTTX) Short Interest Update

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 186,200 shares, a growth of 51.4% from the March 31st total of 123,000 shares. Approximately 8.1% of the shares of the company are sold short. Based on […]

Metaverse Dualchain Network Architecture (DNA) Price Up 0% This Week

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 186,200 shares, a growth of 51.4% from the March 31st total of 123,000 shares. Based on an average daily trading volume, of 78,500 shares, the days-to-cover ratio […]

Short Interest in Better Therapeutics, Inc (NASDAQ:BTTX) Increases By 51 4%

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 186,200 shares, a growth of 51.4% from the March 31st total of 123,000 shares. Approximately 8.1% of the company’s stock are sold short. Based on an average […]

Lake Street Capital Cuts Better Therapeutics (NASDAQ:BTTX) Price Target to $5 00

Better Therapeutics (NASDAQ:BTTX – Get Rating) had its price objective trimmed by Lake Street Capital from $6.00 to $5.00 in a report published on Friday morning, The Fly reports. A number of other brokerages have also issued reports on BTTX. Lifesci Capital lowered shares of Better Therapeutics from an outperform rating to a market perform […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.